(Q45937747)

English

Prognostic value of Bcl-2 and Bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus Calmette-Guerin immunotherapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Prognostic value of Bcl-2 and Bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus Calmette-Guerin immunotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

1 reference

based on heuristic

inferred from title

author name string

Faouzia Ajili

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Belhassen Kaabi

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Amine Darouiche

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Haifa Tounsi

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Nadia Kourda

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Mohamed Chebil

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Mohamed Manai

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Samir Boubaker

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Ultrastructural Pathology

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

36

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

31-39

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Toward an understanding of the molecular mechanisms of physiological cell death.

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Immunohistochemical evaluation of p53, proliferating cell nuclear antigen (PCNA) and bcl-2 expression during bacillus Calmette-Guerin (BCG) intravesical instillation therapy for superficial bladder cancers

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Bladder cancer. I. Molecular and genetic basis of carcinogenesis

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2011.620221

21 January 2018

Identifiers

10.3109/01913123.2011.620221

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22292735

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45937747&oldid=1230831068"